STOCK TITAN

Celcuity (CELC) 424B Filings

CELC NASDAQ

Here are the 424B prospectus supplements from Celcuity Inc. (CELC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow CELC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CELC filings page.

Rhea-AI Summary

Celcuity Inc. is offering $500,000,000 aggregate principal amount of 0.250% Convertible Senior Notes due 2032. The company expects net proceeds of approximately $484.3 million (before over-allotment) and intends to repay its term loans under the A&R Loan Agreement and use the remainder for working capital and general corporate purposes.

The notes carry an initial conversion rate of 8.0302 shares per $1,000 principal (initial conversion price of approximately $124.53 per share). Celcuity’s common stock closed at $88.95 on June 3, 2026. The offering settles on or about June 8, 2026 and includes a 30-day underwriter option for an additional $75,000,000.

Rhea-AI Summary

Celcuity Inc. is offering $400,000,000 aggregate principal amount of % convertible senior notes due 2032 (up to $460,000,000 if underwriters exercise the over-allotment). The indenture will be unsecured, senior and will not contain meaningful financial covenants. Net proceeds are intended to repay the A&R Loan Agreement and for working capital and general corporate purposes.

The company reported Phase 3 VIKTORIA-1 PIK3CA MT results: median progression-free survival was 11.1 months versus 5.6 months (HR = 0.50; 95% CI: 0.37-0.68; p < 0.0001). Celcuity expects to submit a sNDA to the FDA in Q3 2026 and the FDA assigned a PDUFA goal date of July 17, 2026. As of March 31, 2026, cash and cash equivalents were $145.2 million and total long-term indebtedness was $339.1 million; after giving effect to this offering and the stated use of proceeds, long-term indebtedness would be $601.3 million.